Health Canada Issued Notice of Compliance With Conditions Approving Janssen's Darzalex

Johnson & Johnson

• Janssen Inc says Health Canada has issued a notice of compliance with conditions approving Darzalex

• Janssen Inc says Darzalex approved by Health Canada for for treatment of multiple Myeloma

• Janssen Inc says product approved on condition that co carries out confirmatory trials to verify clinical benefit of Darzalex

Back to news